| 83.00 Delayed Data As of 6:30pm ET |  +2.16 / +2.67%Today’s Change | 34.75 Today|||52-Week Range 83.57 | +113.42% Year-to-Date |
| Here's Why You Should Retain Nevro (NVRO) in Your Portfolio Aug 19 / Zacks.com - Paid Partner Content | Nevro Corp (NVRO) Q2 2019 Earnings Call Transcript Aug 10 / MotleyFool.com - Paid Partner Content |
| Nevro (NVRO) Catches Eye: Stock Jumps 6.3% Aug 13 / Zacks.com - Paid Partner Content | Nevro (NVRO) Q2 Loss Wider Than Expected, Revenues Down Y/Y Aug 09 / Zacks.com - Paid Partner Content |
| Previous close | 80.84 |
| Today’s open | 80.78 |
| Day’s range | 80.44 - 83.02 |
| Volume | 345,973 |
| Average volume (3 months) | 468,363 |
| Market cap | $2.5B |
| Earnings growth (last year) | -30.98% |
| Earnings growth (this year) | -137.77% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +18.56% |
| P/E ratio | NM |
| Price/Sales | 3.02 |
| Price/Book | 9.98 |
| Today’s change | Today’s % change | |
|---|---|---|
| IRTCIrhythm Technologies... | +0.53 | +0.71% |
| TNDMTandem Diabetes Care... | +2.13 | +3.60% |
| BEATBioTelemetry Inc | -0.41 | -0.99% |
| NTUSNatus Medical Inc | -0.71 | -2.29% |
| Next reporting date | November 11, 2019 |
| EPS forecast (this quarter) | -$0.83 |
| Annual revenue (last year) | $387.3M |
| Annual profit (last year) | -$49.2M |
| Net profit margin | -12.70% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer D. Keith Grossman |
Vice President- Operations Patrick Schmitz |
Corporate headquarters Redwood City, California |
